Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Hoffmann

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Neuro-Oncology|November 1, 2023
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapyStefanie Krassnig, Stefan L Leber, Andrea Orthmann, et al.
Cancer Research|July 3, 2008
Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopiloneJens Hoffmann, Ilio Vitale, Bernd Buchmann, et al.
Genome Medicine|August 13, 2010
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasetsCharles Swanton, James M Larkin, Marco Gerlinger, et al.
Biorxiv : the Preprint Server for Biology|December 20, 2023
Integration of ζ-deficient CARs into the <i>CD3-zeta</i> gene conveys potent cytotoxicity in T and NK cellsJonas Kath, Clemens Franke, Vanessa Drosdek, et al.
Blood|March 17, 2024
Integration of ζ-deficient CARs into the CD3ζ gene conveys potent cytotoxicity in T and NK cellsJonas Kath, Clemens Franke, Vanessa Drosdek, et al.
Oncotarget|December 20, 2017
Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, et al.
Oncotarget|February 6, 2023
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, et al.
Gastroenterology|October 27, 2025
Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancreatic CancerHazal Köse, Christian Schneeweis, Philipp Putze, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2018
Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progressionNadine Gantenbein, Eva Bernhart, Ines Anders, et al.
Molecular Cancer|May 29, 2023
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancerSandra Kendzia, Susanne Franke, Tarek Kröhler, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Neuro-Oncology|November 1, 2023
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapyStefanie Krassnig, Stefan L Leber, Andrea Orthmann, et al.
Cancer Research|July 3, 2008
Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopiloneJens Hoffmann, Ilio Vitale, Bernd Buchmann, et al.
Genome Medicine|August 13, 2010
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasetsCharles Swanton, James M Larkin, Marco Gerlinger, et al.
Biorxiv : the Preprint Server for Biology|December 20, 2023
Integration of ζ-deficient CARs into the <i>CD3-zeta</i> gene conveys potent cytotoxicity in T and NK cellsJonas Kath, Clemens Franke, Vanessa Drosdek, et al.
Blood|March 17, 2024
Integration of ζ-deficient CARs into the CD3ζ gene conveys potent cytotoxicity in T and NK cellsJonas Kath, Clemens Franke, Vanessa Drosdek, et al.
Oncotarget|December 20, 2017
Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, et al.
Oncotarget|February 6, 2023
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, et al.
Gastroenterology|October 27, 2025
Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancreatic CancerHazal Köse, Christian Schneeweis, Philipp Putze, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2018
Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progressionNadine Gantenbein, Eva Bernhart, Ines Anders, et al.
Molecular Cancer|May 29, 2023
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancerSandra Kendzia, Susanne Franke, Tarek Kröhler, et al.
Pageof 9